Abstract: The invention is concerned with a pharmaceutical and industrial iodophor preparation, its synthesis and potential applications. The compound has predictable antimicrobial activities. Furthermore, this iodophor is much more stable in the presence of organic material than traditional iodophors. The compositions release free iodine when in solution, which provides the antimicrobial activity.

Abstract: The invention provides treatments of organic waste. The invention provides a method for treating organic waste (and in particular, animal waste such as waste from a cow) and uses of a composition that is capable of generating a reactive species in methods of reducing biological degradation of organic waste, in the treatment of organic waste. The invention also provides organic waste treated by the methods of the invention and uses of this treated organic waste. The invention also provides a method for improving the production of volatile fatty acids (VFA) and medium-chain carboxylic acids (MCCAs) during anaerobic digestion (AD) of organic waste.

Abstract: The invention relates to the use of an antibiotic-free antimicrobial feed additive in a method of improving the health of animals and/or reducing methane production of animals. The invention also provides an antimicrobial composition which is used at a low concentration, an antimicrobial composition which has a low ratio of iodide ions to hydrogen peroxide, and uses of these compositions as antimicrobial agents. The invention also provides the use of an antimicrobial composition in combination with an antibiotic as an antimicrobial agent.

Abstract: The present application relates to an anti-microbial system for use in the treatment of microbial infections or control of microbial contamination, which avoids the use of antibiotics. Such infections include mastitis, tuberculosis, cystic fibrosis and the contamination that may result from biofilm formation on medical devices.

Abstract: The present application relates to an anti-microbial system for use in the treatment of microbial infections or control of microbial contamination, which avoids the use of antibiotics. Such infections include mastitis, tuberculosis, cystic fibrosis and the contamination that may result from biofilm formation on medical devices.

Abstract: This invention relates to a method for preparing compositions for preventing or treating microbial infections, compositions suitable for use in such treatments and methods for treatment or prevention of infections. One such composition finds particular use in treating mastitis in ruminants. The composition is administered into the udder of an animal as a highly effective treatment for mastitis, or as a prophylactic therapy, by means of an intra-mammary infusion. The milk produced by the animal, during treatment using the composition and method of the invention, is free of residues, such as antibiotics, antimicrobial agents or antimicrobial proteins, which could affect its suitability for drinking or in the production of milk products, such as cheese or yoghurt. The compositions and methods are also useful in treating and preventing lung infections; and infections in burns and wounds; and other infections caused by biofilms. The compositions may also be used on medical devices to prevent infection.

Abstract: The present invention relates to an anaerobic reactor for the treatment of industrial and other wastewaters at psychrophilic temperatures, the reactor comprising a mixing chamber in which is located, during use, a granular sludge fluidised bed, the reactor further comprising a biofilm chamber fed from the mixing chamber and housing a biofilm colonised pumice-based carrier material, and a separation chamber in fluid communication with the biofilm chamber and in which treated effluent and biogas produced within the reactor are separated.

Abstract: The present invention relates to an anaerobic reactor (10) for the treatment of industrial and other wastewaters at psychrophilic temperatures, the reactor comprising a mixing chamber (12) in which is located, during use, a granular sludge fluidized bed, the reactor further comprising a biofilm chamber (16) fed from the mixing chamber and housing a biofilm colonized pumice-based carrier material, and a separation chamber (18) in fluid communication with the biofilm chamber and in which treated effluent and biogas produced within the reactor are separated.

Abstract: The invention is concerned with a pharmaceutical and industrial iodophor preparation, its synthesis and potential applications. The compound has predictable antimicrobial activities. Furthermore, this iodophor is much more stable in the presence of organic material than traditional iodophors. The compositions release free iodine when in solution, which provides the antimicrobial activity.

Abstract: This invention relates to a method for preparing compositions for preventing or treating microbial infections, compositions suitable for use in such treatments and methods for treatment or prevention of infections. One such composition finds particular use in treating mastitis in ruminants. The composition is administered into the udder of an animal as a highly effective treatment for mastitis, or as a prophylactic therapy, by means of an intra-mammary infusion. The milk produced by the animal, during treatment using the composition and method of the invention, is free of residues, such as antibiotics, antimicrobial agents or antimicrobial proteins, which could affect its suitability for drinking or in the production of milk products, such as cheese or yoghurt. The compositions and methods are also useful in treating and preventing lung infections; and infections in burns and wounds; and other infections caused by biofilms. The compositions may also be used on medical devices to prevent infection.

Abstract: The present application relates to an anti-microbial system for use in the treatment of microbial infections or control of microbial contamination, which avoids the use of antibiotics. Such infections include mastitis, tuberculosis, cystic fibrosis and the contamination that may result from biofilm formation on medical devices.

Abstract: The present invention relates to an anaerobic reactor (10) for the treatment of industrial and other wastewaters at psychrophilic temperatures, the reactor comprising a mixing chamber (12) in which is located, during use, a granular sludge fluidised bed, the reactor further comprising a biofilm chamber (16) fed from the mixing chamber and housing a biofilm colonised pumice-based carrier material, and a separation chamber (18) in fluid communication with the biofilm chamber and in which treated effluent and biogas produced within the reactor are separated.